Outcome to erlotinib in non-small cell lung cancer (NSCLC) patients (p) according to the presence of the EGFR T790M mutation and BRCA1 mRNA expression levels in pretreatment biopsies

Rosell, R. ; Molina, M. A. ; Costa, C. ; Taron, M. ; Bertran-Alamillo, J. ; Mayo, C. ; Benlloch, S. ; Moran, T. ; Cardenal, F. ; Porta, R.

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.7514-7514 [Periódico revisado por pares]

Texto completo disponível